Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Microbiol Biotechnol ; 22(5): 622-7, 2012 May.
Article in English | MEDLINE | ID: mdl-22561855

ABSTRACT

Mast cells and basophils are important effector cells in immunoglobulin-E (IgE)-mediated allergic reactions. Using the human basophilic KU812F cells, we assessed the inhibitory effects of 6-methoxyluteolin, isolated from Chrysanthemum zawadskii, in the FcεRI-mediated allergic reaction. We determined that 6-methoxyluteolin inhibited anti-FcεRI α chain antibody (CRA-1)-induced histamine release, as well as elevation of intracellular calcium concentration [Ca2+]i in a dose-dependent manner. Moreover, the inhibitory effects of 6-methoxyluteolin on the cell surface expression and the mRNA level of the FcεRI α chain were determined by flow cytometric analysis and reverse transcription-polymerase chain reaction (RTPCR), respectively. Therefore, these results show that 6- methoxyluteolin is a potent inhibitor of histamine release and calcium influx via down-regulation of the FcεRI α chain.


Subject(s)
Anti-Allergic Agents/pharmacology , Calcium/immunology , Chrysanthemum/chemistry , Down-Regulation/drug effects , Histamine Release/drug effects , Hypersensitivity/immunology , Luteolin/pharmacology , Plant Extracts/pharmacology , Receptors, IgE/genetics , Anti-Allergic Agents/isolation & purification , Cell Line , Humans , Hypersensitivity/drug therapy , Hypersensitivity/genetics , Immunoglobulin E/immunology , Luteolin/isolation & purification , Mast Cells/drug effects , Mast Cells/immunology , Plant Extracts/isolation & purification , Receptors, IgE/immunology
2.
Exp Biol Med (Maywood) ; 235(10): 1194-203, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20876082

ABSTRACT

We have reported recently that enrichment of high-density lipoprotein (HDL) with phosphatidylcholine (PC) liposomes is effective in solubilizing cholesterol from isolated human atherosclerotic plaques. In the present study, we investigated the in vivo effect of enrichment of HDL with PC on regression of diet-induced atherosclerosis in rabbits. As part of the study, a preliminary in vitro study on blood collected from the cholesterol-fed rabbits was performed to assess the capacity of the HDL density (d > 1.063 g/mL) plasma fraction from cholesterol-fed rabbits to assimilate multilamellar liposomes of synthetic dimyristoylphosphatidylcholine (DMPC). This was compared with the capacities of egg- and soy-PC liposomes to be assimilated into the HDL density plasma fraction. The capacity of the HDL density fraction to absorb PC from DMPC liposomes (11.5 mg/mL) was more than 10 times greater than egg or soy liposomes. Therefore, DMPC liposomes were chosen to infuse into cholesterol-fed rabbits. Cholesterol-fed rabbits infused weekly with DMPC liposomes (300 mg/kg body weight) for five weeks had significantly decreased aortic cholesterol contents (P < 0.05) compared with saline-infused cholesterol-fed controls. Atherosclerotic plaque volume, as measured by a type of new magnetic resonance imaging analysis, also decreased significantly (P < 0.05) after DMPC treatment. The present findings suggest that the enrichment of HDL with PC via intravenous infusion of synthetic DMPC liposomes could be a potential therapeutic approach for atherosclerotic plaque regression.


Subject(s)
Atherosclerosis/blood , Atherosclerosis/drug therapy , Dimyristoylphosphatidylcholine/administration & dosage , Lipoproteins, HDL/blood , Animals , Aorta/pathology , Atherosclerosis/pathology , Cholesterol/blood , Cholesterol, Dietary/administration & dosage , In Vitro Techniques , Infusions, Intravenous , Liposomes/administration & dosage , Male , Rabbits
3.
J Med Food ; 12(2): 383-8, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19459741

ABSTRACT

Human basophilic KU812F cells express a high-affinity immunoglobulin (Ig) E receptor, FcepsilonRI, which plays an important role in IgE-mediated allergic reactions. Houttuynia cordata Thunb (Family Saururaceae), which is rich in polyphenols, has been shown to have various physiological properties, including antiviral, antioxidative, anticancer, and anti-inflammatory activities. The effect of H. cordata extract on the expression of FcepsilonRI in human KU812F cells was examined. Flow cytometric analysis showed that the FcepsilonRI expression and the IgE binding activity were suppressed when the cells were cultured with H. cordata extract. Reverse transcription-polymerase chain reaction analysis showed that levels of the mRNAs for FcepsilonRI alpha- and gamma-chains were decreased by the treatment of H. cordata extract. Addition of H. cordata extract to culture medium was also observed to result in a reduction in the release of histamine from the cells. These results suggest that H. cordata extract may exert its anti-allergic activity through down-regulation of FcepsilonRI expression and a subsequent decrease in histamine release.


Subject(s)
Anti-Allergic Agents/pharmacology , Basophils/drug effects , Drugs, Chinese Herbal/pharmacology , Histamine Antagonists/pharmacology , Houttuynia , Immunoglobulin E/metabolism , Receptors, IgE/metabolism , Cell Line , Down-Regulation , Flavonoids/pharmacology , Flow Cytometry , Histamine/metabolism , Humans , Phenols/pharmacology , Polyphenols , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction
4.
Mol Cells ; 25(2): 172-7, 2008 Apr 30.
Article in English | MEDLINE | ID: mdl-18414002

ABSTRACT

Eukaryotic translation initiation factor 5B (eIF5B) plays a role in recognition of the AUG codon in conjunction with translation factor eIF2, and promotes joining of the 60S ribosomal subunit. To see whether the eIF5B proteins of other organisms function in Saccharomyces cerevisiae, we cloned the corresponding genes from Oryza sativa, Arabidopsis thaliana, Aspergillus nidulans and Candida albican and expressed them under the control of the galactose-inducible GAL promoter in the fun12Delta strain of Saccharomyces cerevisiae. Expression of Candida albicans eIF5B complemented the slow-growth phenotype of the fun12Delta strain, but that of Aspergillus nidulance did not, despite the fact that its protein was expressed better than that of Candida albicans. The Arabidopsis thaliana protein was also not functional in Saccharomyces. These results reveal that the eIF5B in Candida albicans has a close functional relationship with that of Sacharomyces cerevisiae, as also shown by a phylogenetic analysis based on the amino acid sequences of the eIF5Bs.


Subject(s)
Candida albicans/metabolism , Eukaryotic Initiation Factors/metabolism , Saccharomyces cerevisiae/metabolism , Amino Acid Sequence , Candida albicans/cytology , Eukaryotic Initiation Factors/chemistry , Genetic Complementation Test , Immunoblotting , Molecular Sequence Data , Phenotype , Phylogeny , Saccharomyces cerevisiae/cytology , Sequence Alignment
5.
J Ethnopharmacol ; 102(3): 313-8, 2005 Dec 01.
Article in English | MEDLINE | ID: mdl-16081232

ABSTRACT

The effects of methanol extract and gallic acid (3,4,5-trihydroxybenzoic acid) of Orostachys japonicus A. Berger on hepatic drug metabolizing enzymes and lipid peroxidation were investigated in rats treated with bromobenzene. The methanol extract of Orostachys japonicus reduced the activities of phase I enzymes, aminopyrine N-demethylase and aniline hydroxylase, that had been increased by i.p. injection of bromobenzene. Gallic acid isolated from Orostachys japonicus also reduced the aniline hydroxylase activity, while it did not affect the aminopyrine N-demethylase activity. The methanol extract and gallic acid restored the activity of epoxide hydrolase which had been decreased by bromobenzene. Hepatic glutathione content was lowered, along with increase in hepatic lipid peroxide, by bromobenzene administration. The hepatic lipid peroxidation induced by bromobenzene was prevented with the methanol extract and gallic acid of Orostachys japonicus. However, the decrease in glutathione was not altered by gallic acid. The present results suggest that the methanol extract and gallic acid of Orostachys japonicus may protect liver from bromobenzene toxicity through, at least in part, inhibiting the cytochrome P450-dependent monooxygenase activities and enhancing the activity of epoxide hydrolase. Antioxidant effect also may contribute to the protection of Orostachys japonicus against the bromobenzene-induced hepatotoxicity.


Subject(s)
Crassulaceae/chemistry , Gallic Acid/pharmacology , Lipid Peroxidation/drug effects , Liver/drug effects , Plant Extracts/pharmacology , Aminopyrine N-Demethylase/metabolism , Animals , Bromobenzenes/metabolism , Bromobenzenes/toxicity , Glutathione/metabolism , Liver/metabolism , Male , Rats , Rats, Sprague-Dawley
6.
Phytother Res ; 18(1): 19-24, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14750195

ABSTRACT

Effects of the methanol extract of Cirsium japonicum var. ussuriense and hispidulin 7-O-neohesperidoside isolated from the plant on hepatic alcohol-metabolizing enzymes and lipid peroxidation were studied in rats treated with ethanol. Rats treated with 10% alcohol solution for 6 weeks were orally administered with 250 or 500 mg of methanol extract or 10 or 20 mg of hispidulin 7-O-neohesperidoside per kg body weight daily during the last week of ethanol treatment. The administration of the methanol extract of herbal plant and hispidulin 7-O-neohesperidoside in ethanol-treated rats significantly enhanced the activities of hepatic alcohol dehydrogenase, microsomal ethanol-oxidizing system and aldehyde dehydrogenase in a dose-dependent manner. The extract and the compound decreased hepatic lipid peroxidation along with an increase in hepatic content of reduced glutathione. The methanol extract and hispidulin 7-O-neohesperidoside of C. japonicum var. ussuriense also increased the activity of glutathione reductase, but had no effect on gamma-glutamylcysteine synthase. The results suggest that C. japonicum var. ussuriense may alleviate alcoholic toxicity by enhancing ethanol oxidation as well as inhibiting lipid peroxidation, and hispidulin 7-O-neohesperidoside is one of the active substances responsible for the protective effects of this plant.


Subject(s)
Chemical and Drug Induced Liver Injury/prevention & control , Cirsium , Flavones , Flavonoids/pharmacology , Lipid Peroxidation/drug effects , Phytotherapy , Plant Extracts/pharmacology , Protective Agents/pharmacology , Administration, Oral , Animals , Chemical and Drug Induced Liver Injury/enzymology , Chemical and Drug Induced Liver Injury/etiology , Dipeptides/drug effects , Ethanol , Flavonoids/administration & dosage , Flavonoids/therapeutic use , Glutathione Reductase/drug effects , Mitochondria, Liver/drug effects , Plant Components, Aerial , Plant Extracts/administration & dosage , Plant Extracts/therapeutic use , Protective Agents/administration & dosage , Protective Agents/therapeutic use , Rats , Rats, Sprague-Dawley , Thiobarbituric Acid Reactive Substances
7.
Biosci Biotechnol Biochem ; 67(5): 945-50, 2003 May.
Article in English | MEDLINE | ID: mdl-12834269

ABSTRACT

The effect of methanol extract and protocatechuic acid from the leaves of Zanthoxylum piperitum on lipid peroxidation and drug metabolizing enzymes were investigated in the liver of bromobenzene-treated rats. The methanol extract and protocatechuic acid reduced the level of lipid peroxide induced by bromobenzene. The methanol extract and protocatechuic acid reduced the activity of aniline hydroxylase that had been increased by bromobenzene, while did not affect the activities of aminopyrine N-demethylase and glutathione S-transferase. The methanol extract and compound effectively restored the activity of epoxide hydrolase which had been decreased by bromobenzene. These results may suggest that the methanol extract of Z. piperitum and protocatechuic acid prevented lipid peroxidation by reducing the activity of aniline hydroxylase, an epoxide-producing enzyme, and by enhancing the activity of epoxide hydrolase, an epoxide-removing enzyme, in rats that had been intoxicated with bromobenzene.


Subject(s)
Anticarcinogenic Agents/pharmacology , Hydroxybenzoates/pharmacology , Lipid Peroxidation/drug effects , Liver/enzymology , Pharmaceutical Preparations/metabolism , Zanthoxylum/chemistry , Animals , Bromobenzenes/pharmacology , Epoxide Hydrolases/metabolism , Epoxy Compounds/metabolism , Glutathione/metabolism , Liver/drug effects , Male , Methanol , Plant Extracts/pharmacology , Plant Leaves/chemistry , Protein Biosynthesis , Rats , Rats, Sprague-Dawley , Solvents
SELECTION OF CITATIONS
SEARCH DETAIL
...